Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 10/20 | 0.59 |
| ▸ | CYP11B2 | P19099 | 10/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.58 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | DHODH | Q02127 | 1/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17918031 | 0.96 | CYP11B1 (0.58) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL17917880 | 0.94 | CYP11B1 (0.61) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL19637997 | 0.93 | CYP11B1 (0.60) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL19638272 | 0.92 | CYP11B1 (0.66) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL21725403 | 0.92 | CYP11B1 (0.66) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL21725417 | 0.91 | CYP11B1 (0.58) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL19638082 | 0.91 | CYP11B1 (0.64) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL21725414 | 0.91 | CYP11B1 (0.58) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL17917954 | 0.90 | CYP11B1 (0.60) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL21317598 | 0.90 | CYP11B1 (0.59) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10950797-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2021-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10950797-B2 | Organic electroluminescent device | SLC29A2, SLC29A1, NUDT1 | CYP11B1 1493/4885CYP11B2 1102/4885CYP19A1 1301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.